# EDGAR Filing Document

**Accession Number:** 0001524566
**File Stem:** 0002078580-25-000003
**Filing Date:** 2025-12
**Character Count:** 14227
**Document Hash:** 803fa4320599258a0812b983f2ac95b0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002078580-25-000003.hdr.sgml**: 20251211

**ACCESSION NUMBER**: 0002078580-25-000003

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251211

**FILED AS OF DATE**: 20251211

**DATE AS OF CHANGE**: 20251211

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Wetterwald Julien
- **CENTRAL INDEX KEY:** 0002078580

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42987
- **FILM NUMBER:** 251566327

**MAIL ADDRESS:**
- **STREET 1:** C/O WEALTHFRONT CORPORATION
- **STREET 2:** 261 HAMILTON AVE
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94301
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** WEALTHFRONT CORP
- **CENTRAL INDEX KEY:** 0001524566
- **STANDARD INDUSTRIAL CLASSIFICATION:** FINANCE SERVICES [6199]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 208280144
- **STATE OF INCORPORATION:** CA
- **FISCAL YEAR END:** 0731

**BUSINESS ADDRESS:**
- **STREET 1:** 261 HAMILTON AVE
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94301
- **BUSINESS PHONE:** (844) 995-8437

**MAIL ADDRESS:**
- **STREET 1:** 261 HAMILTON AVE
- **CITY:** PALO ALTO
- **STATE:** CA
- **ZIP:** 94301

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WEALTHFRONT Corp
- **DATE OF NAME CHANGE:** 20181002

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** WEALTHFRONT INC
- **DATE OF NAME CHANGE:** 20110629

## Ex-24

**LIMITED POWER OF ATTORNEY**

The undersigned hereby constitutes and appoints David Fortunato, Alan Imberman, and Lauren Lin (each, an "***Attorney-in-Fact***"), as long as such individual is providing services to Wealthfront Corporation, a Delaware corporation (the "***Company***"), acting individually, as the undersigned's true and lawful attorney-in-fact to:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer and/or director of the Company, Forms 3, 4, and 5, and any amendments thereto, in accordance with Section 16(a) of the Securities Exchange Act of 1934 (as amended, the "***Exchange Act***"), and the rules and regulations thereunder;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Forms 3, 4, and 5, and any amendments thereto, and file such forms with the United States Securities and Exchange Commission and any stock exchange or similar authority, if required; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) take any other action of any type whatsoever in connection with the foregoing that, in the opinion of the Attorney-in-Fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by the Attorney-in-Fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as the Attorney-in-Fact may approve in the Attorney-in-Fact's discretion.

The undersigned hereby grants to the Attorney-in-Fact full power and authority to do and perform each and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution and revocation, hereby ratifying and confirming all that the Attorney-in-Fact, or the Attorney-in-Fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing Attorney-in-Fact, in serving in such capacity at the request of the undersigned, is not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act.

The undersigned agrees that the Attorney-in-Fact may rely entirely on information furnished orally or in writing by the undersigned to the Attorney-in-Fact. The undersigned also agrees to indemnify and hold harmless the Company and the Attorney-in-Fact against any losses, claims, damages or liabilities (or actions in these respects) that arise out of or are based on any untrue statement or omission of necessary facts in the information provided by the undersigned to the Attorney-in-Fact for purposes of executing, acknowledging, delivering and filing Forms 3, 4, or 5 (including amendments thereto) and agrees to reimburse the Company and the Attorney-in-Fact for any legal or other expenses reasonably incurred in connection with investigating or defending against any such loss, claim, damage, liability or action.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of, and transactions in securities issued by, the Company, unless earlier revoked by the undersigned in a signed writing delivered to the Attorney-in-Fact.

**IN WITNESS WHEREOF**, the undersigned has caused this Power of Attorney to be executed as of this 15<sup>th</sup> day of July, 2025.

By:

<u>/s/ Julien Wetterwald</u>

Name:

Julien Wetterwald

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Wetterwald Julien<br><sub>(Last) (First) (Middle)</sub><br>C/O WEALTHFRONT CORPORATION<br>261 HAMILTON AVENUE<br><sub>(Street)</sub><br>PALO ALTO, CA 94301<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>WEALTHFRONT CORP [ WLTH ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-12-11 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_Chief Technology Officer_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 233076 | D |  |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Stock Option (Right to Buy) | <sup>(1)</sup> | 2026-08-10 | Common Stock | 24000 | $2.45 | D |  |
| Stock Option (Right to Buy) | <sup>(2)</sup> | 2027-02-09 | Common Stock | 52500 | $2.67 | D |  |
| Stock Option (Right to Buy) | <sup>(3)</sup> | 2027-10-17 | Common Stock | 25000 | $1.67 | D |  |
| Stock Option (Right to Buy) | <sup>(4)</sup> | 2027-10-17 | Common Stock | 30000 | $1.67 | D |  |
| Stock Option (Right to Buy) | <sup>(5)</sup> | 2028-02-13 | Common Stock | 57501 | $1.50 | D |  |
| Stock Option (Right to Buy) | <sup>(6)</sup> | 2028-08-22 | Common Stock | 250000 | $1.79 | D |  |
| Stock Option (Right to Buy) | <sup>(7)</sup> | 2029-10-29 | Common Stock | 150000 | $1.92 | D |  |
| Restricted Stock Units | <sup>(8)</sup> | <sup>(9)</sup> | Common Stock | 328400 | <sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(11)</sup> | <sup>(9)</sup> | Common Stock | 95785 | <sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(12)</sup> | <sup>(9)</sup> | Common Stock | 326200 | <sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(13)</sup> | <sup>(9)</sup> | Common Stock | 337800 | <sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(14)</sup> | <sup>(9)</sup> | Common Stock | 167290 | <sup>(10)</sup> | D |  |
| Restricted Stock Units | <sup>(15)</sup> | <sup>(9)</sup> | Common Stock | 304000 | <sup>(10)</sup> | D |  |

---

### Footnotes:

(1) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on July 1, 2020.

(2) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on January 1, 2021.

(3) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on July 1, 2021.

(4) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on August 23, 2021.

(5) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on December 27, 2021.

(6) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on July 1, 2022.

(7) The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on September 17, 2023.

(8) The award was granted subject to a performance-based vesting condition which shall be satisfied in connection with the Issuer's initial public offering ("IPO"), as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of September, December, March, and June, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on September 15, 2022. Time-vested portions of the award will be settled for shares of the Issuer's Common Stock in connection with the IPO.

(9) These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date

(10) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

(11) The award was granted subject to a performance-based vesting condition which shall be satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested as to 1/8 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2023. The award was fully time-vested as of December 15, 2024, and the entire award will be settled for shares of the Issuer's Common Stock in connection with the IPO.

(12) The award was granted subject to a performance-based vesting condition which shall be satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2024. Time-vested portions of the award will be settled for shares of the Issuer's Common Stock in connection with the IPO.

(13) The award was granted subject to a performance-based vesting condition which shall be satisfied in connection with the IPO, as well as a service-based vesting schedule. The award vested or vests as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche time-vested on March 15, 2025. Time-vested portions of the award will be settled for shares of the Issuer's Common Stock in connection with the IPO.

(14) The award was granted subject to a performance-based vesting condition which shall be satisfied in connection with the IPO and a service-based vesting requirement which was deemed satisfied as of the grant date, April 29, 2025.  The entire award will be settled for shares of the Issuer's Common Stock in connection with the IPO.

(15) The award was granted subject to a performance-based vesting condition which was satisfied in connection with the IPO, as well as a service-based vesting schedule. The award shall vest as to 1/16 of the total award quarterly on the fifteenth calendar day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on March 15, 2026.

**Signature:** /s/ Lauren Lin, as Attorney-in-Fact  
**Date:** 2025-12-11

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**